Archives
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-09-18
This study identifies striatal dopamine D2 receptor-expressing medium spiny neurons as a circuit-level driver of autistic-like self-grooming and digging after Neuroligin 1 loss. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the work links D2-MSN hyperactivation to PKC overactivation and provides a mechanistic framework for studying restricted and repetitive behavior.
LY2109761: From Smad Signal to Assay Design
2026-09-17
LY2109761 is a TGF-β receptor type I and II dual inhibitor that connects receptor kinase blockade with measurable changes in Smad signaling, invasion, stemness, and treatment response. This guide focuses on causal assay design and interpretation across pancreatic cancer, glioblastoma, and fibrosis models.
Molidustat and the Next HIF Translation Frontier
2026-09-17
Molidustat (BAY85-3934) illustrates how oxygen-sensing biology can move beyond erythropoietin stimulation toward a more integrated translational strategy. By connecting HIF prolyl hydroxylase inhibition with CKD anemia, VHL-dependent HIF-1α turnover, and cardiomyocyte stress biology, this article outlines how researchers can design stronger experiments and interpret HIF pathway data with greater mechanistic precision.
LLY-507: A Context-First SMYD2 Inhibitor Guide
2026-09-16
LLY-507 is a selective SMYD2 inhibitor for connecting substrate methylation with cancer phenotypes and fibrotic signaling. This guide emphasizes evidence-aware assay design, mechanistic interpretation, and the limits of translating preclinical observations across disease models.
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-09-16
This study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links trophoblast iron handling to ferroptosis and syncytialization defects in preeclampsia. Its findings suggest that stabilizing HUWE1 and limiting transferrin receptor 1–dependent iron uptake may protect placental function, although clinical translation remains to be established.
Faropenem Sodium: Mechanism, Evidence, and Limits
2026-09-15
Faropenem sodium is an orally bioavailable penem antibiotic that inhibits bacterial cell wall synthesis through penicillin-binding protein engagement. Its broad in vitro spectrum supports controlled antimicrobial research, but the absence of routine clinical breakpoints and documented resistance concerns require evidence-based interpretation.
SB-505124 hydrochloride Workflows
2026-09-15
SB-505124 hydrochloride provides reversible control of ALK4, ALK5, and ALK7 signaling for fibrosis, differentiation, and mechanobiology experiments. This guide connects phospho-Smad assays with fibroblast activation, glaucoma filtration models, and cancer-cell stiffness studies while emphasizing practical controls and troubleshooting.
Thiamet G: A Metabolic Lens on O-GlcNAc
2026-09-14
Thiamet G is a selective O-GlcNAcase inhibitor for dissecting how O-GlcNAcylation connects signaling, metabolism, and cell fate. This article translates recent Wnt–bone biology into practical assay decisions while distinguishing pharmacological modulation from genetic pathway studies.
Bufuralol Hydrochloride: A PK-to-β-Blockade Guide
2026-09-14
Bufuralol hydrochloride is examined here through a practical bridge between β-adrenergic pharmacology and human intestinal pharmacokinetics. Learn how hiPSC-derived organoids can strengthen exposure interpretation without overstating what an intestinal model can prove about cardiovascular activity.
β-Pseudouridine for RNA Workflow Design
2026-09-13
β-Pseudouridine helps researchers connect RNA structure, modification chemistry, and translational fidelity in controlled biochemical workflows. This guide distinguishes the free nucleoside from an incorporation-ready triphosphate and translates recent self-amplifying RNA vaccine findings into practical assay designs, controls, and troubleshooting steps.
Dual HER2–VEGFR2 Targeting in TNBC Metastasis
2026-09-12
The reference study evaluates lapatinib plus Telatinib (BAY 57-9352) in HER2-negative MDA-MB-231 triple-negative breast cancer cells. Its main contribution is linking combined kinase inhibition with reduced proliferation, invadopodia formation, and 2D angiogenic tube formation, while formal pharmacological synergy, direct target engagement, and in vivo efficacy remain unresolved.
EdU Imaging Kits (Cy3) for HCC S-Phase Analysis
2026-09-11
EdU Imaging Kits (Cy3) provide an antibody-free route to visualize DNA synthesis, making S-phase measurements practical in hepatocellular carcinoma models and mechanistic perturbation studies. This guide translates the S100P–MYBL2–AURKB findings into assay design, imaging, flow cytometry, and troubleshooting decisions.
Reactive Oxygen Species Assay Kit for Causal Redox Biology
2026-09-11
The Reactive Oxygen Species Assay Kit enables quantitative ROS detection in live cells while supporting rigorous interpretation of oxidative stress pathways. This guide connects DCFH-DA assay design to the Nrf2 and EGFR/PI3K/AKT findings reported in a PM2.5-induced COPD study.
Sulfo-NHS-SS-Biotin for Surface Proteomics
2026-09-10
Sulfo-NHS-SS-Biotin enables reversible, non-permeant labeling of surface-exposed proteins while preserving a route to mechanistic assay design. This guide explains how to use disulfide cleavage to distinguish cell-surface accessibility, protein organization, and glycoRNA-associated biology.
AZ505: Practical SMYD2 Inhibition Workflows
2026-09-10
AZ505 combines substrate-competitive SMYD2 inhibition with a practical path from purified-enzyme assays to cellular and cisplatin-induced renal fibrosis models. This guide translates its selectivity and potency into assay design, controls, optimization steps, and scientifically bounded applications in epigenetic regulation research and cancer biology research.
739 records 8/50 page Previous Next First page 上5页 678910 下5页 Last page